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Wyatt H. Rivas

Introductory Statement:

My honor's project involved research, determining specific brain regions
affected by autoantibodies in autism, under Dr. Vijendra K. Singh in the
Department of Biology over a one-year period.

During that time, I've been

exposed to a wide variety of bench research methods and protocols. As part of
the undergraduate research training, I also received training in laboratory safety
and blood-borne pathogen handling and was certified by the Environmental
Health and Safety Center on campus. The whole experience has been a wide
eye opener.

I've learned a tremendous amount, namely skills and knowledge

that I'll carry with me throughout my career, under the tutelage of Dr. Singh. I
presented our research on April 1yth at the annual 2003 student showcase (See
miniature version of the poster on next page). The following is a description of
our research.
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ABSTRACT:

Autism, a neurodevelopmental disorder, may involve abnormal immune
reaction such as autoimmunity to the brain.

Autoimmunity

is generally

characterized by the presence of organ-specific autoantibodies, for example the
brain-specific

autoantibodies

in autism. Thus, we conducted

a study of

autoantibodies against three brain regions, including the caudate-putamen
nucleus (CP), cerebral cortex (CC), and cerebellum (CE). These brain regions
were dissected out from the brain of a Sprague-Dawley rat and homogenized for
protein

separation

by

SOS-PAGE.

Autoantibodies

were

detected

by

immunoblotting technique in the serum of autistic children (n=42) and normal
children (n=11 ).

We found that many autistic children had autoantibodies to

neural proteins: 46% of sera were positive for CP, 20% of sera were positive for
CC, and 2% of sera were positive for CE. Normal children did not harbor these
autoantibodies.

Because of the highest number of autistic sera positive for

autoantibodies to CP, we suggest that the caudate-putamen nucleus might be
affected in the brain of autistic children. Subsequently, we made a supernatant
(CPS) of the CP homogenate
autoantibodies.

and repeated immunoblotting

assays for

We detected autoantibodies to three proteins of the CPS with

molecular weights of approximately 160 kD, 115 kD and 49 kD. The nature of
these proteins is currently under investigation.
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INTRODUCTION:
Autism is an early-onset disorder of the developing central nervous
system (CNS). The disorder causes severe deficits of higher mental functions
such as social interaction, language, communication, imagination and cognition.
Today, autism is the fastest-growing developmental disability [1]. Autism affects
more than one-half of a million Americans and millions more worldwide but very
little is known about the etiology and pathogenesis of the disorder.
Current theories include genetic factors, immune factors, environmental
factors and yet other unidentified factors [2,3]. We focused on immune factors
such

as autoimmunity

in autism [4,5]. Indeed, the evidence

is rapidly

accumulating to support an "autoimmune hypothesis" in autism, as recently
described in a review article [6]. Autoimmunity in autistic children is shown by
several autoimmune factors: brain-specific autoantibodies

[2,3,7], impaired

lymphocyte functions [8-11], abnormal cytokine regulation [6], viral associations
[12] and indirect association of certain immunogenetic factors [13].
In the present study, our goal was to determine if autistic children harbor
brain-specific autoantibodies particularly with regards to different brain regions.
This study is an extension of a pilot study previously conducted in Dr. Singh's
laboratory [14]. Based on the known neurobiology of autism, we selected three
brain regions: Cerebellum (CE), Cerebral Cortex (CC), and Caudate-Putamen
(CP) nucleus (See Figure 1). Laboratory studies described here provide initial
evidence for an autoimmune reaction to caudate nucleus in children with autistic
disorder.

5

Figure 1: Showing Three Brain Regions Selected in the Study

Cerebral Cortex (CC)

Caudate Putamen (CP)

Cerebellum (CE)
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MATERIALS AND METHODS:

1. Subjects: The study included a total of 53 children: (i) 42 Autistic children; and

(ii) 11 Normal children. Of the 42 autistic children, 5 had a diagnosis of pervasive
developmental disorder (POD) and 37 had a diagnosis of autism. The clinical
diagnosis of autism was made essentially according to the standard DSM-IV
criteria of the American Association of Psychiatrists, Washington, DC. The
Institutional Review Board (IRB) of Utah State University reviewed and approved
our research protocol that involved the use of human blood samples.
2. Brain Autoantibody Detection: This was performed essentially according to

our published methods of immunoblotting technique [4,5, 12]. A Sprague-Dawley
rat was sacrificed to remove brain. Then the brain was dissected to collect
caudate-putamen (CP), cerebral cortex (CC) and cerebellum (CE). Their location
in the human brain is diagramatically shown in Figure 1. Each brain region was
separately homogenized in Tween-20 containing Tris-Buffered Saline (TBST)
and stored frozen. Later on in the study, the CP homogenate was centrifuged in
a microcentrifuge to make CP supernatant (CPS).
3. Protein Electrophoresis

& Transfer: The separate brain regions were each

combined with a 4X sample buffer in a microcentrifuge tube and boiled for five
minutes and then allowed to cool. Using a micropipette, 100 microliter aliquots
were placed in a long horizontal well along the top of the gels. Standards were
also placed in side wells. The electrophoresis apparatus was turned on and the
proteins migrated down the gel with the help from a 150 mV current for about an

7

hour.

The individual proteins were separated out by molecular weight, larger

proteins move slower, during this step. The proteins were then transferred onto
nitrocellulose membranes (NCMs).

To do this, each gel was sandwiched on

either side by a sponge, blotting paper, and NCM (See "Sandwich" diagram).
After securing the sandwich they were placed in a transfer buffer and left for 2024 hours. The NCM's were dried and then blocked for a minimum of 2 hours by
soaking in 100 ml of TBST buffer (Tris-Buffered Saline Tween) containing 1%
(w/v) bovine serum albumin (BSA).

4. Immunoassay: The NCMs, after blocking with BSA, were used for antibody
detection by our standard immunoblotting procedure.

The NCMs were cut into

narrow blots (3-4 mm wide) and placed in a 1:25 pre-dilution serum/ TBS. After
incubation for an hour the blots were washed three times with TBST. Then they
were incubated in the presence of the secondary antibody that was alkaline
phosphatase-conjugated-goat-antihuman
1 :2,500).

immunoglobulins

(pre-diluted

at

This is a polyvalent antibody that contains lgG, lgM and lgA. Again

this was allowed to incubate for an hour and again washed three times with
TBST.

The blots were incubated in the color reagent (AP substrate reagent

purchased from Bio-Rad Labs.) and the color was allowed to develop. A reaction
was scored positive if a purplish-blue band appeared (See Figure 2). During the
experiment, all serum samples were treated the same. To prevent potential bias,
all samples were analyzed in a double-blind fashion and the code was broken
after the completion of the laboratory analysis.
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Sandwich Diagram
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RESULTS and DISCUSSION:

At first, the brain proteins of CP, CC and CE were separated from different
regions and transferred to nitrocellulose membranes. This was followed by
immunoassays in the presence of patient or control serum, which served as the
source of autoantibody. The representative positive reactions are shown in
Figure 2. Autistic serum showed a positive reaction but normal serum did not.
The autoantibody screen revealed that the highest number of autoantibodypositive autistic sera was with the CP region (46%) as compared to CC region
(20%) or CE region (2%) (Figure 3). This finding suggests that the neurons in
the caudate nucleus (CP) might be a target of autoimmune pathology in autism
but more research is necessary to firmly establish this observation.
Because CP region was the most immunoreactive region, an attempt was
made to extract proteins from this brain region followed by immunoblotting. First,
the protein patterns of CP homogenate and CP supernatant (CPS) were
resolved. The protein patterns of CP (Figure 4a) and CPS (Figure 4b) resembled
quite closely. Then, the immunoassay with autistic sera showed that they were
positive for two major proteins in CP (Figure 5); they had molecular weights of
approximately 160,000 and 115,000 (Figure 6a). These two proteins also showed
positive reaction in CPS but an additional protein band was positive at a
molecular weight of approximately 49,000 (Figure 5 & 6b). Considering the fact
that CP and CPS contain a large number of proteins, it is interesting to find only
two or three proteins showing autoantibody positive reactions in autistic children.

This must imply a significant level of specificity with respect to the proteins of the
CP region. Once they have been fully characterized, these proteins could
potentially serve as markers of neuropathology in autism. This aspect of brainautoimmunity and autism research is currently under investigation in Dr. Singh's
laboratory. In summary, the key findings of this study are:
1. We found that approximately 46% of autistic children but none of the
normal children harbored brain-specific autoantibodies,

in particular

autoantibodies to caudate nucleus of the brain.
2. Approximately 20% of autistic children also had antibodies to cerebral
cortex. Normal children did not harbor these antibodies.
3. Only one out of 37 autistic children (a very low number of positive sera)
had antibodies to cerebellum.
4. In the caudate nucleus, the immunoreactive proteins showed approximate
molecular weights of 160 kD, 115 kD and 49 kD.

CONCLUSION:

We detected a significant percentage of autoantibodies to the caudate
nucleus of the brain in autistic children, and none in normal children. Three
unique caudate nucleus proteins were isolated and molecular weights
determined. This is the first study of this kind. This new immunological
evidence

may suggest

the

involvement

neuropathology of autism.
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FIGURE 2

Normal Autistic
Serum Serum

Caudate Putamen (CP)

Normal
Serum

Autistic
Serum

Cerebral Cortex (CC)

Normal
Serum

Autistic
Serum

Cerebellum (CE)

Figure 2. Typical immunoblots of CP, CC, and CE autoantibodies: Note that the
black arrows are pointing to positive bands due to antibodies in autistic children
but not in normal children.
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FIGURE 3

Antibody Distribution in Brain Regions
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Figure 3. Distribution of brain autoantibodies in three different brain
regions. Note that the highest number of autistic sera (17/37) were
positive for CP proteins but not for CC or CE proteins.

15

FIGURE 4a & 4b
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/ Fig. 4b. CPS gel showing Protein Pattern
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FIGURE 5

➔

Autistic Sera

Autistic Sera

Caudate Putamen (CP) ➔➔➔ Caudate Putamen
Supernatant (CPS)

Figure 5. Representative CP& CPS immunoblots reacted with autistic sera.
Note that black arrows point to positive reactions. These bands corresponded to
proteins of 160 kD, 115 kD and 49 kD molecular weights as shown in Figures 6a
& 6b on the next page).
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FIGURE 6a & 6b
Molecular Weight of CP+ Proteins
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Figure 6a & 6b. Molecular weight determination of CP and CPS Proteins
immuno-reactive for autoantibodies. Note that autoantibodies reacted to two
major proteins (160 kD and 115 kD) in both CP (Fig.6a) and CPS (Fig. 6b), plus
a third protein (49 kD) in CPS only.
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